Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors

References

• Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4:253–65.
   PubMed Web of Science ®Google Scholar
• Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer. 2010;10:194–204.
   PubMed Web of Science ®Google Scholar
• Nogales E. Structural insights into microtubule function. Ann Rev Biochem. 2000;69:277–302.
   PubMed Web of Science ®Google Scholar
• Jordan A, Hadfield JA, Lawrence NJ, McGown AT. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 1998;18:259–96.
   PubMed Web of Science ®Google Scholar
• Risinger AL, Giles FJ, Mooberry SL. Microtubule dynamics as a target in oncology. Cancer Treat Rev. 2009;35:255–61.
   PubMed Web of Science ®Google Scholar
• Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene. 2003;22:9075–86.
   PubMed Web of Science ®Google Scholar
• Dumontet C, Jordan MA. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov. 2010;9:790–803.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629–61.
   PubMed Web of Science ®Google Scholar
• Yao H, Liu J, Xu S, Zhu Z, Xu J. The structural modification of natural products for novel drug discovery. Expert Opin Drug Discov. 2017;12:121–40.
   PubMed Web of Science ®Google Scholar
• Li G, Lou H-X. Strategies to diversify natural products for drug discovery. Med Res Rev. 2018;38:1255–94.
   PubMed Web of Science ®Google Scholar
• Thomford NE, Senthebane DA, Rowe A, Munro D, Seele P, Maroyi A, Dzobo K. Natural products for drug discovery in the 21st century: Innovations for novel drug discovery. Int J Mol Sci 2018;19(6):1578.
   PubMed Web of Science ®Google Scholar
• Haustedt LO, Mang C, Siems K, Schiewe H. Rational approaches to natural-product-based drug design. Curr Opin Drug Discov Devel. 2006;9:445–62.
   PubMedGoogle Scholar
• Kingston DGI. Tubulin-interactive natural products as anticancer agents. J Nat Prod. 2009;72:507–15.
   PubMed Web of Science ®Google Scholar
• Yue Q-X, Liu X, Guo D-A. Microtubule-binding natural products for cancer therapy. Planta Med. 2010;76:1037–43.
   PubMed Web of Science ®Google Scholar
• Dall’Acqua S. Natural products as antimitotic agents. Curr Top Med Chem. 2014;14:2272–85.
   PubMed Web of Science ®Google Scholar
• Carlson RO. New tubulin targeting agents currently in clinical development. Expert Opin Investigat Drugs. 2008;17:707–22.
   PubMed Web of Science ®Google Scholar
• Wang Y-S, Wen Z-Q, Li B-T, Zhang H-B, Yang J-H. Ethnobotany, phytochemistry, and pharmacology of the genus litsea: an update. J Ethnopharmacol. 2016;181:66–107.
   PubMed Web of Science ®Google Scholar
• Jia X, Li P, Wan J, He C. A review on phytochemical and pharmacological properties of litsea coreana. Pharm Biol. 2017;55:1368–74.
   PubMed Web of Science ®Google Scholar
• Kong D-G, Zhao Y, Li G-H, et al. The genus litsea in traditional chinese medicine: an ethnomedical, phytochemical and pharmacological review. J Ethnopharmacol. 2015;164:256–64.
   PubMed Web of Science ®Google Scholar
• Li L, Zhao X, Luo Y, Zhao J, Yang X, Zhang H. Novel cytotoxic chalcones from litsea rubescens and litsea pedunculata. Bioorg Med Chem Lett. 2011;21:7431–3.
   PubMed Web of Science ®Google Scholar
• Sharma R, Kumar R, Kodwani R, Kapoor S, Khare A, Bansal R, Khurana S, Singh S, Thomas J, Roy B, et al. A review on mechanisms of anti tumor activity of chalcones. Anticancer Agents Med Chem. 2015;16:200–11.
   PubMed Web of Science ®Google Scholar
• Ducki S. Antimitotic chalcones and related compounds as inhibitors of tubulin assembly. Anticancer Agents Med Chem. 2009;9:336–47.
   PubMed Web of Science ®Google Scholar
• Lawrence NJ, McGown AT. The chemistry and biology of antimitotic chalcones and related enone systems. Curr Pharm Des. 2005;11:1679–93.
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Shokrzadeh M, Modanloo M, Ziar A, Riazi GH, Emami S. New indole-based chalconoids as tubulin-targeting antiproliferative agentsd. Bioorg Chem. 2017;75:86–98.
   PubMed Web of Science ®Google Scholar
• Wang G, Li C, He L, Lei K, Wang F, Pu Y, Yang Z, Cao D, Ma L, Chen J. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Bioorg Med Chem. 2014;22:2060–79.
   PubMed Web of Science ®Google Scholar
• Wang G, Qiu J, Chen M, Xiao X, Cao A, Li L. Synthesis, biological evaluation and docking studies of (e)-3-aryl-2-(3,4,5-trimethoxybenzoyl) acrylonitrile derivatives as anticancer agents. Latin Am J Pharmacy. 2017;36:1739–45.
   Web of Science ®Google Scholar
• Wang G, Peng Z, Zhang J, Qiu J, Xie Z, Gong Z. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site. Bioorg Chem. 2018;78:332–40.
   PubMed Web of Science ®Google Scholar
• Wang G, Qiu J, Xiao X, Cao A, Zhou F. Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents. Bioorg Chem. 2018;76:249–57.
   PubMed Web of Science ®Google Scholar
• Borowiak M, Nahaboo W, Reynders M, Nekolla K, Jalinot P, Hasserodt J, Rehberg M, Delattre M, Zahler S, Vollmar A, et al. Photoswitchable inhibitors of microtubule dynamics optically control mitosis and cell death. Cell. 2015;162:403–11.
   PubMed Web of Science ®Google Scholar
• Perez EA. Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther. 2009;8:2086–95.
   PubMed Web of Science ®Google Scholar
• Sun M, Qin J, Kang Y, Zhang Y, Ba M, Yang H, Duan Y, Yao Y. 2-methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response. Bioorg Chem. 2022;120:105625.
   PubMed Web of Science ®Google Scholar
• Wang G, Liu W, Fan M, He M, Li Y, Peng Z. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors. J Enzyme Inhib Med Chem. 2021;36:1694–702.
   PubMed Web of Science ®Google Scholar